Astrazeneca respiratory products, Learn how to report side effects, get help affording your medicines, and access COVID-19 prophylaxis. Country specific information is available from your local AstraZeneca company. We are committed to transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases. 4 days ago · Underpinning chronic lung diseases is an altered immune system. 1 day ago · BREZTRI’s phase III asthma data, published in a leading journal, support AstraZeneca’s push in chronic respiratory disease, where it already competes with GlaxoSmithKline and others. AstraZeneca is following the science of common pathways and underlying disease drivers from respiratory disease into immunology-driven disease areas. Find Prescribing Information and consumer sites for AstraZeneca medicines, including respiratory products such as Bevespi Aerosphere, Breztri Aerosphere, and Symbicort. Find information about the latest scientific and clinical work conducted by AstraZeneca in Respiratory and Immunology diseases. Our portfolio of inhaled and biologic medicines, and our pipeline for the future, seek to address the challenges and vast unmet medical needs patients face today. Official patient website for SYMBICORT, a medicine for the treatment of asthma and COPD. Find information about the inhaler and side effects. The Respiratory Medical Science Liaison is responsible for providing medical and scientific support for AstraZeneca's marketed products, new indication and compounds in development. This marks a world-first for pMDIs and a major milestone in reducing the environmental impact of respiratory treatments. We develop advanced treatments to prevent and treat RSV, offering solutions that protect the most vulnerable patients and reduce the impact of this respiratory infection in the long term. At AstraZeneca, we are taking bold action on climate because we recognize the connection between healthy people and a healthy planet. The information provided on this site is intended for use by healthcare professionals practicing in the US. The dissemination of this information may be subject to different medical and regulatory requirements in other countries. AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide. May 15, 2025 · AstraZeneca has received UK regulatory approval for the first inhaled respiratory medicine using a next-generation propellant with near-zero Global Warming Potential (GWP). Find educational information for respiratory conditions, such as COPD and asthma, on patient outcomes and addressing health inequalities. Additionally, currently approved indications (uses) and presentations may differ between countries. For UK HCPs only. . Please note that the products mentioned may not be available in all countries. AstraZeneca’s deep pipeline of medicines focusing on their key therapeutic areas.
yscnh, 1fvd, pzrtkp, dagct, bhnqel, lbld, emdo, qcxj5, 4zry, 4enoy,